Ken Griffin Enochian Biosciences Inc Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
8,700 New
8,700 $40,000
Q3 2023

Nov 14, 2023
SELL
$0.0 - $4.46 $0 - $36,572
-8,200 Reduced 68.91%
3,700 $16,000
Q2 2023

Aug 14, 2023
BUY
$0.4 - $1.3 $4,760 - $15,470
11,900 New
11,900 $6,000
Q4 2022

Feb 14, 2023
BUY
$1.03 - $2.13 $12,978 - $26,838
12,600 New
12,600 $12,000

Others Institutions Holding ENOB

# of Institutions
51
Shares Held
14.7M
Call Options Held
24K
Put Options Held
19.1K
View Full List

About Enochian Biosciences Inc

ENOB Quotes by TradingView
  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email